{
  "abstract": "The 2026 American Diabetes Association (ADA) Standards of Care position diabetes technologies as integral components of routine diabetes management rather than optional adjuncts, reflecting a shift towards broader eligibility, earlier initiation and sustained access across care settings. 1 Across device categories, the guidance emphasises individualised, patient-centred selection, with technology choice informed by personal circumstances, preferences and capabilities and caregiver involvement where relevant.1",
  "authors": [
    {
      "affiliations": [
        "Medical School, Aston University, Birmingham, UK"
      ],
      "name": "Khashayar Saybani"
    },
    {
      "affiliations": [
        "Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"
      ],
      "name": "Ishani Ajantha Attanayake Mukaweti Sahabandu Mudiyanselage"
    },
    {
      "affiliations": [
        "Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"
      ],
      "name": "Ainan Arshad"
    }
  ],
  "title": "Implementing ADA 2026 diabetes technology recommendations: opportunities and challenges for quality improvement in real-world care",
  "uid": "d79c2e2a-c39d-511c-b598-7d6b5ac35604"
}